Friday, November 6, 2026
HomeETFsXERS Crosses Above Average Analyst Target

XERS Crosses Above Average Analyst Target

In recent trading, shares of Xeris Biopharma Holdings Inc (Symbol: XERS) have crossed above the average analyst 12-month target price of $12.86, changing hands for $13.08/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down

www.nasdaq.com

RELATED ARTICLES

Most Popular

Recent Comments